https://newconnect.pl/komunikat?geru_id=161382&title=Receiving+a+Notice+of+Allowance+for+U.S+Patent++related+to+Cosmetic+Injection+System
With this patent in hand, The Board of Directors of the Company looks forward to advancing the commercial roll-out of the cosmetic injection instrument in the U.S., which has the potential to significantly impact the safety and administration of botulinum toxin. The market opportunity for the cosmetic instrument includes over 8.4 million botulinum toxin injections delivered annually in the U.S. alone.